Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: Immunohistological demonstration of the involvement of 5-HT(1B)-receptors

British Journal of Clinical Pharmacology

Volumn 46, Issue 6, 1998, Pages 577-582

  Longmore, J ^a   Razzaque, Z ^a   Shaw, D ^a   Davenport, A P ^b   Maguire, J ^b   Pickard, J D ^b   Schofield, W N ^a   Hill, R G ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

5 HT(1B 1D) receptor agonists; Human arteries; Vasoconstriction

Indexed keywords

RIZATRIPTAN; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN AGONIST; SUMATRIPTAN;

ARTICLE; BRAIN ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG POTENCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MENINGEAL ARTERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; VASOCONSTRICTION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY VESSELS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL ARTERIES; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SUMATRIPTAN; TRIAZOLES; TRYPTAMINES; VASOCONSTRICTOR AGENTS;

EID: 0031753796     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00821.x     Document Type: Article

References (24)

1. Humphrey PPA, Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Tr Pharmacol Sci 1991; 12: 444-446.
2. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 1991; 338: 13-17.
3. Caekebeke JFV, Ferrari MD, Zetsloot CP, Jansen J, Saxena P. Antimigraine drug sumatriptan increases blood flow velocity in cerebral arteries during migraine attacks. Neurol 1992; 42: 1522-1526.
4. 1Dβ receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 1993; 44: 242-246.
5. 1D-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new anti-migraine drugs. Cephalalgia, 1997; 17: 833-842.
6. Ullmer C, Schmuck K, Kalkman & Lubbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Letts 1995; 370: 215-221.
7. Kaumann AJ, Parsons AA, Brown AM. Human arterial constrictor serotonin receptors Cardiovasc Res 1993; 27: 2094-2103.
8. 1D receptor subtypes. Tr Pharmacol Sci 1996; 44: 103-105.
9. van Es NM, Bruning TA, Camps J, et al. Assessment of peripheral vascular effects of antimigraine drugs in humans. Cephalalgia 1995; 15: 288-291.
10. 1D receptor subtype. In 5-hydroxytryptamine mechanisms in primary headache, ed. Olesen J, Saxena PR. 1992; Raven Press, New York, pp 178-182.
11. MacIntyre PD, Bhargave B, Hogg KJ, Gemmill JD, Hillis WS. The effect of i.v. sumatriptan, a selective 5-HT-1-receptor agonist, on central haemodynamics and the coronary circulation. Br J Clin Pharmacol 1992; 34: 541-546.
12. Willet F, Curzen N, Adams J, Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan. Br Med J 1992; 304: 1415.
13. O'Connor P, Gladstone P. Oral sumatriptan-associated myocardial infarction. Neurol 1995; 45: 2274-2276.
14. 1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: outcome from two independent studies using different experimental protocols. FUnctional Neurol 1997; 12: 3-9.
15. Longmore J, Hargreaves R, Razzaque Z, et al. Rizatriptan selectively contracts human isolated middle meningeal artery over coronary artery: comparisons with sumatriptan. Headache 1997; 5: 322.
16. 1DD-receptor subtype specific antibodies. J Neurosci Methods 1997; 80: 155-161.
17. 1D agonist. Br J Clin Pharmacol 1997; 43: 49-54.
18. 2 receptors in serotonin-induced contraction of human isolated coronary arteries. Circulation 1994; 90: 1141-1153.
19. 2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Br J Pharmacol 1996; 117: 283-292.
20. 1 receptors by sumatriptan. Br J Pharmacol 1991; 102: 16P.
21. H-receptor activation. Br J Clin Pharmacol 1998; (in press).
22. 1Dβ-receptor binding affinity. Br J Pharmacol 1996; 119: 112P.
23. 1-like receptor agonist, GR43175. Cephalalgia 1989; 9(Suppl 9): 21-23.
24. 2 receptor activation. Eur J Pharmacol 1992; 161: 91-94.